Policy priorities

From National Cancer Control Policy
Prostate cancer > Policy priorities

Export options


Home > Prostate cancer > Policy priorities

Overview   Impact   Prevention   Screening   Policy context   Policy priorities   Position statements
NCPP prostate banner.png


Policy priorities


Table 1. Strategy for improving outcomes from early detection of prostate cancer

Support a patient centred approach for individual decisions about PSA testing
Policy priority/action Agency Estimated cost Expected benefit Comments
Educate and resource GPs and other health professionals to assist men to make an informed decision on PSA testing Medical colleges, Cancer Councils Reduction in harms relating to PSA testing. See Potential benefits and harms of prostate cancer screening
Develop decision making tools for informed choice about prostate cancer screening for medical practitioners and consumers Medical colleges, Cancer Councils Low cost Reduction in harms relating to PSA testing. See Potential benefits and harms of prostate cancer screening
Research into prostate cancer diagnosis and treatment, in particular, the development of an accurate test to detect the potentially lethal form of prostate cancer
Policy priority/action Agency Estimated cost Expected benefit Comments
Support research into an improved prostate cancer screening test that can detect the potentially lethal form of prostate cancer Cancer Councils, Cancer Australia, National Health and Medical Research Council, research agencies Improved detection of clinically significant prostate cancers and improved prostate cancer morbidity and mortality outcomes
Support research into improving treatments for early stage prostate cancer to reduce side-effects Cancer Councils, Cancer Australia, National Health and Medical Research Council, research agencies Improved prostate cancer morbidity and mortality outcomes
Encourage the development of national, evidence-informed guidelines relating to PSA testing
Policy priority/action Agency Estimated cost Expected benefit Comments
Advocate for and contribute to developing national, evidence-informed consensus guidelines for screening PSA testing and care consequent on positive screening PSA tests Multiple agencies led by Cancer Australia or Department of Health and Ageing More consistent approach to PSA testing and potential subsequent treatment

Back to top